Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |